⌘K

Login Start Free

Home/Filings/4/0001209191-23-050094

4//SEC Filing

Tada Hiroomi 4

Accession 0001209191-23-050094

CIK 0001863127other

View on SEC.gov Company Profile

Filed

Sep 18, 8:00 PM ET

Accepted

Sep 19, 7:37 PM ET

Size

4.6 KB

Accession

0001209191-23-050094

Insider Transaction Report

Form 4

Period: 2023-09-15

Tyra Biosciences, Inc.TYRA

Chief Medical Officer

Transactions

Award
Common Stock
2023-09-15$6.58/sh+1,337$8,796→ 84,467 total

Footnotes (1)

[F1]These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Tyra Biosciences, Inc.

CIK 0001863127

Entity typeother

Related Parties

1

filerCIK 0001880593

Filing Metadata

Form type: 4
Filed: Sep 18, 8:00 PM ET
Accepted: Sep 19, 7:37 PM ET
Size: 4.6 KB

View on SEC.gov